Contineum Therapeutics, Inc.

CTNM chart

Contineum Therapeutics, Inc. news

• Why Is Contineum Therapeutics (NASDAQ:CTNM) Up 3.49% Premarket?

  Kalkine · Oct 26, 6:29 AM EDT

• Contineum Therapeutics, Inc. Estimates – NASDAQ:CTNM

  TradingView · Oct 23, 10:53 AM EDT

• BMY Reports Mixed Phase III Trial Results, Stock Down

  Yahoo Finance · Oct 13, 12:40 PM EDT

• Bristol Myers Reverses Lower Despite Double Phase 3 Win, As A Key Rival Crashes

  Yahoo Finance · Oct 12, 4:14 PM EDT

• Bristol Myers Stock Tumbles on ‘Confounding’ Trial Results

  Yahoo Finance · Oct 12, 2:46 PM EDT

• All You Need to Know About Contineum Therapeutics, Inc. (CTNM) Rating Upgrade to Buy

  Yahoo Finance · Oct 12, 11:00 AM EDT

• Contineum Therapeutics Shares Surge 27% After Bristol Myers Squibb Reports Positive Phase 3 Trial Results

  investorshub.advfn.com · Oct 12, 8:42 AM EDT

• Contineum drops 25% on mixed Bristol Myers IPF data; Stifel keeps Buy rating

  Yahoo Finance · Oct 12, 7:55 AM EDT

• Bristol Myers trial revisions shake confidence in new class of fibrosis drugs

  biopharmadive.com · Sep 30, 12:22 PM EDT

• J&J and Contineum’s Depression Drug Missed Phase 2 Goal. What Comes Next?

  Yahoo Finance · Sep 24, 7:04 PM EDT

• Sector Update: Healthcare Stocks Ease Late Afternoon

  Yahoo Finance · Sep 15, 3:52 PM EDT

• FDA clears first generic radioligand drug; Sionna turns to layoffs

  biopharmadive.com · Sep 15, 1:13 PM EDT

Contineum Therapeutics, Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-K8-K2026-09-14
• 10-Q10-Q2026-07-30
• 8-K8-K2026-07-30
• 8-K8-K2026-07-13
• 8-K8-K2026-06-26
• 10-Q10-Q2026-05-05
• 8-K8-K2026-05-05
• DEF 14ADEF 14A2026-04-30
• 8-K8-K2026-04-30
• 10-K10-K2026-03-05
• 8-K8-K2026-03-05
• 8-KFORM 8-K2026-01-26

About Contineum Therapeutics, Inc.

Ticker

CTNM (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

San Diego, CA

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1855175

Frequently asked questions